Search

Amber D. Steele

Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )

Most Active Art Unit
1658
Art Unit(s)
1654, 1639, 1658, 1676
Total Applications
1302
Issued Applications
628
Pending Applications
166
Abandoned Applications
538

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6602257 [patent_doc_number] => 20100322979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'Peptidomimetic Resorbable Peptide-Polymer Hybrid Polyester Nanoparticles' [patent_app_type] => utility [patent_app_number] => 12/820683 [patent_app_country] => US [patent_app_date] => 2010-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5757 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0322/20100322979.pdf [firstpage_image] =>[orig_patent_app_number] => 12820683 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/820683
Peptidomimetic Resorbable Peptide-Polymer Hybrid Polyester Nanoparticles Jun 21, 2010 Abandoned
Array ( [id] => 10898103 [patent_doc_number] => 08921317 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-12-30 [patent_title] => 'Nano-recombinant fibrinogen for fibrin sealants' [patent_app_type] => utility [patent_app_number] => 12/814078 [patent_app_country] => US [patent_app_date] => 2010-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 6566 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12814078 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/814078
Nano-recombinant fibrinogen for fibrin sealants Jun 10, 2010 Issued
Array ( [id] => 7651830 [patent_doc_number] => 20110301099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'Method for enhancing penetration of lipid insoluble medicaments through cell membranes using small S-Allyl-containing molecules with phospholipid permeability as carrier molecules' [patent_app_type] => utility [patent_app_number] => 12/802354 [patent_app_country] => US [patent_app_date] => 2010-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1892 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301099.pdf [firstpage_image] =>[orig_patent_app_number] => 12802354 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/802354
Method for enhancing penetration of lipid insoluble medicaments through cell membranes using small S-Allyl-containing molecules with phospholipid permeability as carrier molecules Jun 3, 2010 Abandoned
Array ( [id] => 6062073 [patent_doc_number] => 20110200560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'NON-IONIC SELF-ASSEMBLING PEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/787546 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11194 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200560.pdf [firstpage_image] =>[orig_patent_app_number] => 12787546 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/787546
NON-IONIC SELF-ASSEMBLING PEPTIDES AND USES THEREOF May 25, 2010 Abandoned
Array ( [id] => 7807174 [patent_doc_number] => 20120058127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'PAR2 Agonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections' [patent_app_type] => utility [patent_app_number] => 13/266799 [patent_app_country] => US [patent_app_date] => 2010-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9567 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058127.pdf [firstpage_image] =>[orig_patent_app_number] => 13266799 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/266799
PAR2 agonists for use in the treatment or prevention of influenza virus type A infections May 2, 2010 Issued
Array ( [id] => 7777243 [patent_doc_number] => 20120040365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'NEW COMPETENCE STIMULATING PEPTIDE' [patent_app_type] => utility [patent_app_number] => 13/266103 [patent_app_country] => US [patent_app_date] => 2010-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9983 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040365.pdf [firstpage_image] =>[orig_patent_app_number] => 13266103 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/266103
NEW COMPETENCE STIMULATING PEPTIDE Apr 27, 2010 Abandoned
Array ( [id] => 6493852 [patent_doc_number] => 20100209449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'HAPTEN-CARRIER CONJUGATES FOR USE IN DRUG-ABUSE THERAPY AND METHODS FOR PREPARATION OF SAME' [patent_app_type] => utility [patent_app_number] => 12/766617 [patent_app_country] => US [patent_app_date] => 2010-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 31255 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20100209449.pdf [firstpage_image] =>[orig_patent_app_number] => 12766617 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/766617
HAPTEN-CARRIER CONJUGATES FOR USE IN DRUG-ABUSE THERAPY AND METHODS FOR PREPARATION OF SAME Apr 22, 2010 Abandoned
Array ( [id] => 8197306 [patent_doc_number] => 20120121706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'PAR-1 Activation by Metalloproteinase-1 (MMP-1)' [patent_app_type] => utility [patent_app_number] => 13/263715 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 33662 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20120121706.pdf [firstpage_image] =>[orig_patent_app_number] => 13263715 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/263715
PAR-1 Activation by Metalloproteinase-1 (MMP-1) Apr 11, 2010 Abandoned
Array ( [id] => 6424711 [patent_doc_number] => 20100186633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'PEPTIDE-BASED DIBLOCK AND TRIBLOCK DISPERSANTS AND DIBLOCK POLYMERS' [patent_app_type] => utility [patent_app_number] => 12/754636 [patent_app_country] => US [patent_app_date] => 2010-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 28714 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20100186633.pdf [firstpage_image] =>[orig_patent_app_number] => 12754636 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/754636
PEPTIDE-BASED DIBLOCK AND TRIBLOCK DISPERSANTS AND DIBLOCK POLYMERS Apr 5, 2010 Abandoned
Array ( [id] => 6629746 [patent_doc_number] => 20100311671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'TRANSDERMAL DELIVERY OF PKC MODULATORY PEPTIDES THROUGH MICROPORATED SKIN' [patent_app_type] => utility [patent_app_number] => 12/732091 [patent_app_country] => US [patent_app_date] => 2010-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15699 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311671.pdf [firstpage_image] =>[orig_patent_app_number] => 12732091 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/732091
TRANSDERMAL DELIVERY OF PKC MODULATORY PEPTIDES THROUGH MICROPORATED SKIN Mar 24, 2010 Abandoned
Array ( [id] => 8228388 [patent_doc_number] => 20120142593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'Factor VIII Variants and Methods of Use' [patent_app_type] => utility [patent_app_number] => 13/260564 [patent_app_country] => US [patent_app_date] => 2010-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 20277 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13260564 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/260564
Factor VIII Variants and Methods of Use Mar 23, 2010 Abandoned
Array ( [id] => 6296155 [patent_doc_number] => 20100240598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'PEPTIDES AND PEPTIDE MIMETICS TO INHIBIT THE ONSET AND/OR PROGRESSION OF FIBROTIC AND/OR PRE-FIBROTIC PATHOLOGIES' [patent_app_type] => utility [patent_app_number] => 12/724722 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 45314 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240598.pdf [firstpage_image] =>[orig_patent_app_number] => 12724722 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/724722
PEPTIDES AND PEPTIDE MIMETICS TO INHIBIT THE ONSET AND/OR PROGRESSION OF FIBROTIC AND/OR PRE-FIBROTIC PATHOLOGIES Mar 15, 2010 Abandoned
Array ( [id] => 8056459 [patent_doc_number] => 20120077960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'FLUOROBODIES: INTRINSICALLY FLUORESCENT BINDING LIGANDS' [patent_app_type] => utility [patent_app_number] => 13/256198 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18477 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077960.pdf [firstpage_image] =>[orig_patent_app_number] => 13256198 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/256198
FLUOROBODIES: INTRINSICALLY FLUORESCENT BINDING LIGANDS Mar 11, 2010 Abandoned
Array ( [id] => 7669106 [patent_doc_number] => 20110318375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'Immunomodulatory Therapeutic Agents' [patent_app_type] => utility [patent_app_number] => 13/203045 [patent_app_country] => US [patent_app_date] => 2010-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 26325 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13203045 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/203045
Immunomodulatory Therapeutic Agents Mar 8, 2010 Abandoned
Array ( [id] => 8138341 [patent_doc_number] => 20120093721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'USES OF CANCER-TARGETING PEPTIDES IN CANCER DIAGNOSIS' [patent_app_type] => utility [patent_app_number] => 13/201753 [patent_app_country] => US [patent_app_date] => 2010-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4144 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093721.pdf [firstpage_image] =>[orig_patent_app_number] => 13201753 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/201753
Uses of cancer-targeting peptides in cancer diagnosis Feb 18, 2010 Issued
Array ( [id] => 8630131 [patent_doc_number] => 08362203 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Non-natural peptides as models for the development of antibiotics' [patent_app_type] => utility [patent_app_number] => 12/703255 [patent_app_country] => US [patent_app_date] => 2010-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 93 [patent_figures_cnt] => 110 [patent_no_of_words] => 34631 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12703255 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/703255
Non-natural peptides as models for the development of antibiotics Feb 9, 2010 Issued
Array ( [id] => 6063132 [patent_doc_number] => 20110201048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'SCREENING METHOD OF THERAPEUTIC AND DIAGNOSTIC AGENTS FOR TNF-ALPHA-INDUCED DISEASES USING REACTIVE OXYGEN SPECIES MODULATOR 1' [patent_app_type] => utility [patent_app_number] => 13/126421 [patent_app_country] => US [patent_app_date] => 2010-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4913 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201048.pdf [firstpage_image] =>[orig_patent_app_number] => 13126421 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/126421
SCREENING METHOD OF THERAPEUTIC AND DIAGNOSTIC AGENTS FOR TNF-ALPHA-INDUCED DISEASES USING REACTIVE OXYGEN SPECIES MODULATOR 1 Jan 10, 2010 Abandoned
Array ( [id] => 7766046 [patent_doc_number] => 20120034163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'NON-INVASIVE TOOLS FOR DETECTING VULNERABLE ATHEROSCLEROTIC PLAQUES' [patent_app_type] => utility [patent_app_number] => 13/143920 [patent_app_country] => US [patent_app_date] => 2010-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4874 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034163.pdf [firstpage_image] =>[orig_patent_app_number] => 13143920 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/143920
NON-INVASIVE TOOLS FOR DETECTING VULNERABLE ATHEROSCLEROTIC PLAQUES Jan 4, 2010 Abandoned
Array ( [id] => 6622223 [patent_doc_number] => 20100311047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Identification Of Cancer Protein Biomarkers Using Proteomic Techniques' [patent_app_type] => utility [patent_app_number] => 12/644677 [patent_app_country] => US [patent_app_date] => 2009-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16740 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311047.pdf [firstpage_image] =>[orig_patent_app_number] => 12644677 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/644677
Identification of cancer protein biomarkers using proteomic techniques Dec 21, 2009 Issued
Array ( [id] => 6289536 [patent_doc_number] => 20100158837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'IRON OXIDE-BINDING PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/632827 [patent_app_country] => US [patent_app_date] => 2009-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19837 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158837.pdf [firstpage_image] =>[orig_patent_app_number] => 12632827 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/632827
IRON OXIDE-BINDING PEPTIDES Dec 7, 2009 Abandoned
Menu